1Ajuebor MN,Swain MG,Perretti M,et al. Chemokines as novel therapeutic targets in inflammatory diseases[J]. Biochem Pharmacol, 2002,63 (7): 1191.
2Kennedy J, Kelner GS, Kleyensteuber S, et al. Molecular cloning and functional characterization of human lymphotactin[J]. J Immunol, 1995,155(1):203.
3Christopherson K 2nd, Hromas R. Chemokine regulation of normal and pathologic immune responses [J]. Stem Cells,2004,19(5) :388.
4Haskell CA, Ribeiro S, Horuk R. Cherookines in transplant rejection[J]. Curr Opin Investig Drugs, 2002, 3 (3) :399.
5Inston NG,Cockwell P. The evolving role of chemokines and their receptors in acute allograft rejection[J]. Nephrol Dial Transplant, 2002,17 : 1374.
6Dubinski B, Boratyflska M, Kopec W, et al. Activated cells in urine and monocyte chemotactic peptide-1 (MCP- 1) sensitive rejection markers in renal graft recipients [J]. Transpl Immunol, 2008,18 (3): 203.
7Matz M, Beyer J,Wunsch D, et al. Early post-transplant urinary IP 10 expression after kidney transplantation is predictive of short- and long-term graft function[J]. Kidney Int,2006,69(9) :1683.
8Mayer V,Hudkins KL,Heller F,et al. Expression of the chemokine receptor CCR1 in human renal allografts[J]. Nephrol Dial Transplant,2007,22(6) : 1720.
9Panzer U, Reinking RR, Steinmetz, et al. CXCR3 and CCR5 positive T-cell recruitment in acute human renal allograft rejection [J]. Transplantation, 2004, 78 ( 9 ) : 1341.
10Inston N,Drayson M, Ready A, et al. Serial changes in the expression of CXCR3 and CCR5 on peripheral blood lymphocytes following human renal transplantation[J]. Exp Clin Transplant, 2007,5 (2) : 638.
二级参考文献10
1Fleckenstein JF,Paredes M,Thuluvath PJ.A prospective,randomized,double-blind trial evaluating the efficacy of ursodeoxycholic acid in prevention of liver transplant rejection[J].Liver Transpl Surg,1998,4(4):276-279.
2Zhao Xiao-ming,Hu Yen-ya,Miller GG,et al.Diffe rential expression of the IFN-gamma-inducible CXCR3-binding chemokines,IFN-inducible protein 10,monokine induced by IFN,and IFN-inducible T cell alpha c hemoattractant in human cardiac allografts:association with cardiac allograft v asculopathy and acute rejection[J].J Immunol,2002,169(3):1556-1560.
3Colvin RA,Campanella GS,Sun J,et al.Intracellular d omains of CXCR3 that mediate CXCL9,CXCL10,and CXCL11 function[J].J Biol Chem,2004,279(29):30219-30227.
4Fahmy NM,Yamani MH,Starling RC,et al.Chemokine and receptor-gene expression during early and late acute rejection episodes in hum an cardiac allografts[J].Transplantation,2003,75(12):2044-2047.
5Kanmaz T,Feng P,Torrealba J,et al.Surveillance of acute rejection in baboon renal transplantation by elevation of interferon-gamm a inducible protein-10 and monokine induced by interferon-gamma in urine[J].Transplantation,2004,78(7):1002-1007.
6Kao J,Kobashigawa J,Fishbein MC,et al.Elevated ser um levels of the CXCR3 chemokine ITAC are associated with the development of tra nsplant coronary artery disease[J].Circulation,2003,107(15):1958-1961.
7Meyer M,Hensbergen PJ,van der Raaij-Helmer EM,et al.Cross reactivity of three T cell attracting murine chemokines stimulating the C XC chemokine receptor CXCR3 and their induction in cultured cells and during all ograft rejection[J].Eur J Immunol,2001,31(8):2521-2527.
8Solomon MF,Kuziel WA,Simeonovic CJ.The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allogr afts[J].Cell Transplant,2004,13(5):503-514.
9Hu Huai-zhong,Aizenstein BD,Puchalski A,et al.Elevat ion of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfu nction[J].Am J Transplant,2004,4(3):432-437.
10Hauser IA,Spiegler S,Kiss E,et al.Prediction of acute renal allo graft rejection by urinary monokine induced by IFN-gamma (MIG)[J].J Am Soc Nephrol,2005,16(6):1849-1858.
